VeriMomn-prolyl palmitoyl tripeptide-56 acetate hamilelikte güvenli mi?
No harmonised CLP reproductive classifications (ECHA Annex VI), no SCCS or CIR safety assessment flagging reproductive hazard, and no peer‑reviewed reproductive toxicity data identified (PubMed). As a peptide/lipopeptide there is no specific evidence of reproductive toxicity; therefore default hazard and mechanism scores are 0. Dermal absorption is expected to be low but measurable because of the palmitoyl lipophilic moiety, so exposure is scored low (e=1). Sources consulted: ECHA Annex VI, SCCS/CIR (no entries), PubMed (no reproductive studies), PubChem/CosIng (ingredient listing).
Pregnancy-safe products containing n-prolyl palmitoyl tripeptide-56 acetate
Related ingredients
Frequently asked questions
- n-prolyl palmitoyl tripeptide-56 acetate hamilelikte güvenli mi?
- No harmonised CLP reproductive classifications (ECHA Annex VI), no SCCS or CIR safety assessment flagging reproductive hazard, and no peer‑reviewed reproductive toxicity data identified (PubMed). As a peptide/lipopeptide there is no specific evidence of reproductive toxicity; therefore default hazard and mechanism scores are 0. Dermal absorption is expected to be low but measurable because of the palmitoyl lipophilic moiety, so exposure is scored low (e=1). Sources consulted: ECHA Annex VI, SCCS/CIR (no entries), PubMed (no reproductive studies), PubChem/CosIng (ingredient listing).
- n-prolyl palmitoyl tripeptide-56 acetate emzirirken güvenli mi?
- Same rationale as pregnancy: no reproductive or lactation-specific hazard identified in authoritative sources. No evidence of transfer in milk; dermal exposure from cosmetics is expected to be low but measurable (e=1). Sources: ECHA Annex VI, SCCS/CIR (no entries), PubMed, PubChem/CosIng.
- n-prolyl palmitoyl tripeptide-56 acetate bebek cildi için güvenli mi?
- No infant‑specific hazard data located. Because the ingredient likely has low but measurable dermal absorption in adults (e=1) and infant skin has higher permeability and higher surface‑area‑to‑weight, exposure score is increased by +1 to e=2 for 0–3 year olds. No studies demonstrating infant toxicity were found. Sources: ECHA Annex VI, SCCS/CIR (no entries), PubMed, PubChem/CosIng.
- VeriMom n-prolyl palmitoyl tripeptide-56 acetate nasıl puanlıyor?
- VeriMom n-prolyl palmitoyl tripeptide-56 acetate'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte n-prolyl palmitoyl tripeptide-56 acetate yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.